One ETF Gets a Lift From Rosetta Genomics
February 17, 2015 at 14:56 PM EST
Shares of Rosetta Genomcis (NasdaqGS: ROSG), a micro-cap biotechnology stock, are up nearly 32% after earlier trading up as much as 40% after the company landed U.S. and European patent allowances. The news comes less than a week after Rosetta won a patent allowance in Japan. Rosetta “received a...
